BR9915984A - Método de tratar púrpura trombocitopênica e sìndrome urêmica hemolìtica - Google Patents

Método de tratar púrpura trombocitopênica e sìndrome urêmica hemolìtica

Info

Publication number
BR9915984A
BR9915984A BR9915984-8A BR9915984A BR9915984A BR 9915984 A BR9915984 A BR 9915984A BR 9915984 A BR9915984 A BR 9915984A BR 9915984 A BR9915984 A BR 9915984A
Authority
BR
Brazil
Prior art keywords
thrombocytopenic purpura
uremic syndrome
hemolytic uremic
provides
treating thrombocytopenic
Prior art date
Application number
BR9915984-8A
Other languages
English (en)
Inventor
Charles Jack Fisher
Sau-Chi Betty Yan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9915984A publication Critical patent/BR9915984A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Patente de Invenção: <B>"MéTODO DE TRATAR PúRPURA TROMBOCITOPêNICA E SìNDROME URêMICA HEMOLìTICA"<D>. A presente invenção provê um método para tratar púrpura trombocitopênica trombótica (TTP) e síndrome urêmica hemolítica (HUS) com proteína C. A invenção reivindicada provê uma terapia necessária para um distúrbio potencialmente grave e debilitante ao mesmo tempo que evitando complicações tais como tendência a sangrar, toxicidade, e efeitos colaterais gerais de permuta plasmática ou dos agentes anticoagulantes atualmente disponíveis.
BR9915984-8A 1998-12-10 1999-12-01 Método de tratar púrpura trombocitopênica e sìndrome urêmica hemolìtica BR9915984A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11177098P 1998-12-10 1998-12-10
PCT/US1999/028433 WO2000033867A1 (en) 1998-12-10 1999-12-01 Method of treating thrombocytopenic purpura and hemolytic uremic syndrome

Publications (1)

Publication Number Publication Date
BR9915984A true BR9915984A (pt) 2001-09-04

Family

ID=22340356

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915984-8A BR9915984A (pt) 1998-12-10 1999-12-01 Método de tratar púrpura trombocitopênica e sìndrome urêmica hemolìtica

Country Status (13)

Country Link
US (2) US20010003740A1 (pt)
EP (1) EP1137432B1 (pt)
JP (1) JP2002531519A (pt)
CN (1) CN1329503A (pt)
AT (1) ATE264113T1 (pt)
AU (1) AU1838500A (pt)
BR (1) BR9915984A (pt)
CA (1) CA2351555A1 (pt)
DE (1) DE69916493T2 (pt)
ES (1) ES2219094T3 (pt)
IL (1) IL142249A0 (pt)
WO (1) WO2000033867A1 (pt)
ZA (1) ZA200102730B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002028416A1 (ja) * 2000-09-30 2004-02-12 持田製薬株式会社 溶血性貧血の予防・治療剤
CA2668187A1 (en) * 2006-10-31 2008-06-19 The Scripps Research Institute Dosing regimen of activated protein c and variants having reduced anticoagulant activity
CN105833255A (zh) * 2016-03-23 2016-08-10 兆科药业（合肥）有限公司 抗血小板溶栓素在制备治疗血栓性血小板减少性紫癜的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516650A (en) * 1985-06-27 1996-05-14 Zymogenetics, Inc. Production of activated protein C
ID22933A (id) * 1997-04-28 1999-12-16 Lilly Co Eli Fomulasi protien c terakivasi

Also Published As

Publication number Publication date
US20040087643A1 (en) 2004-05-06
US20010003740A1 (en) 2001-06-14
ZA200102730B (en) 2002-07-03
DE69916493T2 (de) 2005-03-24
EP1137432A1 (en) 2001-10-04
ES2219094T3 (es) 2004-11-16
AU1838500A (en) 2000-06-26
EP1137432B1 (en) 2004-04-14
IL142249A0 (en) 2002-03-10
WO2000033867A1 (en) 2000-06-15
CN1329503A (zh) 2002-01-02
JP2002531519A (ja) 2002-09-24
DE69916493D1 (de) 2004-05-19
ATE264113T1 (de) 2004-04-15
CA2351555A1 (en) 2000-06-15

Similar Documents

Publication Publication Date Title
DE69626660T2 (de) 2-alkylpyrrolidine
UA39099C2 (uk) Циклічні азотовмісні похідні, суміш їх ізомерів або окремі ізомери, або їх солі
WO1999037340A3 (en) Biological fluid treatment system
ES2159318T3 (es) Inhibidores de la proteina quinasa c.
BG101984A (en) Botulinum toxin derivatives able to modify peripheral sensory afferent functions
EP0330047A3 (en) Method for the sterilization of blood, blood derivatives, plasma derivatives, cell suspensions or the like
BR9610838A (pt) Processo para tratar um indivìduo tendo uma condição patológica envolvendo neovascularização.
DK0840606T3 (da) Små di- og trivalente molekyler som selectininhibitorer
AU1565300A (en) Anti-germinating method for tubers and bulbs using eugenol and/or isoeugenol
WO1999036064A3 (en) Methods of treating tardive dyskinesia and other movement disorders
IL142220A0 (en) Method of treating viral hemorrhagic fever
WO2021195470A3 (en) Identification and use of compounds in the treatment or prevention of severe acute respiratory syndrome coronavirus 2
WO2000021513A3 (en) Methods for treating multiple sclerosis
BR9915984A (pt) Método de tratar púrpura trombocitopênica e sìndrome urêmica hemolìtica
AU1171102A (en) Uridine therapy for patients with elevated purine levels
MY113431A (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DE69303305D1 (de) Mittel zur Behandlung chronischer Ermüdungserscheinungen
BR9915317A (pt) Método de tratar trombocitopenia induzida por heparina
HU9700024D0 (en) Imidazopyridin-azolidinones
ZA200102727B (en) Method of treating sickle cell disease or thalassemia.
AU6290398A (en) Inclusion complexes in aqueous solution
ES2122912A1 (es) Inhibidores de metalocarboxipeptidasas y moleculas derivadas como agentes antitumorales.
MXPA02005493A (es) Dicloruro de borato de tris-(3,5-dimetilpirazolil) cromo como componente de sistemas cataliticos para la polimerizacion de olefinas y procedimiento de polimerizacion que lo usa.
DK0535178T3 (da) Halogencarbonhydridfri retardlakopløsning til farmaceutiske præparater
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]